InVivo Therapeutics Holdings Corp. (NVIV) Plunges 10.69% on January 29 – Equities.com

Market Summary Follow

InVivo Therapeutics Holdings Corp. is a InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury.

NVIV - Market Data & News

InVivo Therapeutics Holdings Corp. (NVIV) had a rough trading day for Friday January 29 as shares tumbled 10.69%, or a loss of $-0.14 per share, to close at $1.17. After opening the day at $1.30, shares of InVivo Therapeutics Holdings Corp. traded as high as $1.31 and as low as $1.15. Volume was 5.95 million shares over 15,127 trades, against an average daily volume of n/a shares and a total float of 21.17 million.

As a result of the decline, InVivo Therapeutics Holdings Corp. now has a market cap of $24.77 million. In the last year, shares of InVivo Therapeutics Holdings Corp. have traded between a range of $8.51 and $0.50, and its 50-day SMA is currently $n/a and 200-day SMA is $n/a.

For a complete fundamental analysis of InVivo Therapeutics Holdings Corp., check out Equities.coms Stock Valuation Analysis report for NVIV.

Still paying commissions on stock trades? Equities.com now offers $7.99/month unlimited trading and flat-fee options trading for $89.99/month! Get started today by https://www.equities.com/trading-start

InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.

InVivo Therapeutics Holdings Corp. is based out of Cambridge, MA and has some 6 employees. Its CEO is Richard M. Toselli.

InVivo Therapeutics Holdings Corp. is a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on InVivo Therapeutics Holdings Corp. and to follow the companys latest updates, you can visit the companys profile page here: NVIVs Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.coms Newsdesk. Also, dont forget to sign-up for our daily email newsletter to ensure you dont miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Link:
InVivo Therapeutics Holdings Corp. (NVIV) Plunges 10.69% on January 29 - Equities.com